CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 176 enrolled
Drug / intervention
Photorefractive keratectomy (PRK) +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01699087
NCT01699087N/ACompleted
CompareCT.gov

Prospective Safety and Effectiveness Study of PRK for Myopia With or Without Astigmatism Using the ALLEGRETTO WAVE® EYE-Q Excimer Laser System

Alcon Research·interventional·Posted Oct 3, 2012·Updated Sep 30, 2019

In Brief

A clinical study evaluating Photorefractive keratectomy (PRK) and ALLEGRETTO WAVE EYE-Q excimer laser system for Myopia and Astigmatism. Completed, enrolled 176 participants.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of the ALLEGRETTO WAVE EYE-Q excimer laser system for the reduction of myopia with or without astigmatism in subjects undergoing photorefractive keratectomy (PRK) treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Astigmatism
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 3, 2012
Enrollment StartAug 1, 2012
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 13.7 years ago

Interventions

Photorefractive keratectomy (PRK)procedure

In this corneal surgical procedure, the outer corneal epithelial layer will be removed, after which the corneal stroma will be reshaped by excimer laser ablation to reduce or eliminate refractive errors.

ALLEGRETTO WAVE EYE-Q excimer laser systemdevice

The ALLEGRETTO WAVE EYE-Q excimer laser system is used for corneal stroma reshaping during PRK surgery